China: Chongqing Brewery suspends share trading until the end of September

Chongqing Brewery, controlled by Danish brewer Carlsberg, suspended share trading on the Shanghai bourse on September 16, and announced that its subsidiary vaccine maker Jiachen Biological Engineering will begin a review of its Hepatitis B vaccines research soon, Global Times reported on September 16.

It will resume share trading on September 27 after it announces the curative effects of its vaccines.

Chongqing Brewery's share prices surged 37 times during the period from 1998 to 2011, boosted by the news of its involvement in the pharmaceutical sector. But in January 2012, the company said clinical trials of its vaccines showed that the effectiveness is no different from that of a placebo, causing its share price to drop.

Currently its share prices are at around 17 yuan ($2.78), compared with the price of 80 yuan back in 2011.

17 September, 2013